메뉴 건너뛰기




Volumn 14, Issue 1, 2015, Pages 56-62

Estimation of group means when adjusting for covariates in generalized linear models

Author keywords

Hypoglycemic events; Logistic regression; Negative binomial regression

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; BINOMIAL DISTRIBUTION; DIABETES MELLITUS; HYPOGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; PROBABILITY; REGRESSION ANALYSIS; SIMULATION; STATISTICAL MODEL; CLINICAL TRIAL (TOPIC); HUMAN; STATISTICS AND NUMERICAL DATA;

EID: 84921676349     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1658     Document Type: Article
Times cited : (31)

References (10)
  • 2
    • 84868131614 scopus 로고    scopus 로고
    • Randomized, controlled study of once daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes
    • Bergenstal RM, Rosenstock J, Arakaki RF, Prince MJ, Qu Y, Sinha VP, Howey DC, Jacober SJA. Randomized, controlled study of once daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012; 35:2140-2147.
    • (2012) Diabetes Care , vol.35 , pp. 2140-2147
    • Bergenstal, R.M.1    Rosenstock, J.2    Arakaki, R.F.3    Prince, M.J.4    Qu, Y.5    Sinha, V.P.6    Howey, D.C.7    Jacober, S.J.A.8
  • 3
    • 84869842163 scopus 로고    scopus 로고
    • Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
    • On behalf of the NN1250-3579 (BEGIN Once Long) trial investigators
    • Zinman B, Philis-Tsimikas A, Cariou B, Handelsman Y, Rodbard HW, Johansen T, Endahl L, Mathieu C. On behalf of the NN1250-3579 (BEGIN Once Long) trial investigators. Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long). Diabetes Care 2012; 35:2464-2471.
    • (2012) Diabetes Care , vol.35 , pp. 2464-2471
    • Zinman, B.1    Philis-Tsimikas, A.2    Cariou, B.3    Handelsman, Y.4    Rodbard, H.W.5    Johansen, T.6    Endahl, L.7    Mathieu, C.8
  • 4
    • 84921667031 scopus 로고    scopus 로고
    • Guideline on adjustment for baseline covariates (draft) (accessed 23 February 2014)
    • The Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency. Guideline on adjustment for baseline covariates (draft). Available at: http://www.ema.europa. eu/docs/en-GB/document-library/Scientific-guideline/2013/06/WC500144946.pdf (accessed 23 February 2014).
    • The Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency
  • 5
    • 84880044149 scopus 로고    scopus 로고
    • Comparison of negative binomial regression models in analyzing hypoglycemic events
    • Luo J, Qu Y. Comparison of negative binomial regression models in analyzing hypoglycemic events. Pharmaceutical Statistics 2013; 12:233-242.
    • (2013) Pharmaceutical Statistics , vol.12 , pp. 233-242
    • Luo, J.1    Qu, Y.2
  • 6
    • 84882273956 scopus 로고    scopus 로고
    • The effect of adjusting for baseline hypoglycemia when analyzing hypoglycemia data: A systematic analysis of 15 diabetes clinical trials
    • Luo J, Jacober SJ, Prince MJ, Carey MA, Qu Y. The effect of adjusting for baseline hypoglycemia when analyzing hypoglycemia data: a systematic analysis of 15 diabetes clinical trials. Diabetes Technology and Therapeutics 2013; 15:654-661.
    • (2013) Diabetes Technology and Therapeutics , vol.15 , pp. 654-661
    • Luo, J.1    Jacober, S.J.2    Prince, M.J.3    Carey, M.A.4    Qu, Y.5
  • 7
    • 84921647112 scopus 로고    scopus 로고
    • SAS Institute, Inc. SAS/STAT 9.2 User's Guide. SAS Institute, Inc., Cary: NC, 2009
    • SAS Institute. Inc. SAS/STAT 9.2 User's Guide. SAS Institute, Inc., Cary: NC, 2009.
  • 8
    • 84904129897 scopus 로고    scopus 로고
    • (accessed 15 November 2012)
    • Lenth RV. Using the lsmeans Package. Available at: http://cran. r-project.org/web/packages/lsmeans/vignettes/using-lsmeans.pdf (accessed 15 November 2012).
    • Using the Lsmeans Package
    • Lenth, R.V.1
  • 10
    • 38149073314 scopus 로고    scopus 로고
    • Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
    • Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Diabetes Care 2008; 31:20-25.
    • (2008) Diabetes Care , vol.31 , pp. 20-25
    • Rosenstock, J.1    Ahmann, A.J.2    Colon, G.3    Scism-Bacon, J.4    Jiang, H.5    Martin, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.